Glenmark Pharma gets USFDA nod for progesterone inserts; eyes $59 million market
Glenmark Pharmaceuticals Ltd. on Thursday, April 9, said it has received final approval from the US Food and Drug Administration (USFDA) for its Progesterone Vaginal Inserts, 100 mg, expanding its portfolio in the women’s healthcare segment. The approved product is bioequivalent and therapeutically equivalent to Endometrin Vaginal Inserts, a reference drug of Ferring Pharmaceuticals, the…
